Topical liposomal amphotericin B gel treatment for cutaneous leishmaniasis caused by Leishmania major: a double-blind, randomized, placebo-controlled, pilot study.

Saved in:
Bibliographic Details
Title: Topical liposomal amphotericin B gel treatment for cutaneous leishmaniasis caused by Leishmania major: a double-blind, randomized, placebo-controlled, pilot study.
Authors: Horev A; Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva, Israel.; Pediatric Dermatology Service, Soroka University Medical Center, Beer Sheva, Israel., Sagi O; Parasitology Laboratory, Soroka University Medical Center, Beer Sheva, Israel., Zur E; Compounding Solutions, Tel-Mond, Israel., Ben-Shimol S; Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva, Israel.; Pediatric Infectious Disease Unit, Soroka University Medical Center, Beer Sheva, Israel.
Source: International journal of dermatology [Int J Dermatol] 2023 Jan; Vol. 62 (1), pp. 40-47. Date of Electronic Publication: 2022 Aug 30.
Publication Type: Randomized Controlled Trial; Journal Article
Journal Info: Publisher: Blackwell Science Country of Publication: England NLM ID: 0243704 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-4632 (Electronic) Linking ISSN: 00119059 NLM ISO Abbreviation: Int J Dermatol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1365-4632
DOI:10.1111/ijd.16407